Volume 13, Number 1—January 2007
Research
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*
Table 3
Multivariable analysis of outcomes of patients with and without multidrug-resistant (MDR) Acinetobacter infections, Baltimore hospitals, 2003–2004*
| Outcome evaluated | MDR Acinetobacter vs. susceptible† OR (95% CI) | MDR Acinetobacter vs. uninfected† OR (95% CI) |
|---|---|---|
| Length of stay, d | 2.5 (1.2–5.2) | 2.5 (1.2–5.4) |
| Intensive care unit length of stay, d | 2.1 (1.0–4.3) | 4.2 (1.5–11.6) |
| Mortality rate (%) | 2.6 (0.3–26.1) | 6.6 (0.4–108.3) |
*OR, odds ratio; CI, confidence interval.
†Models include modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.
Page created: June 28, 2010
Page updated: June 28, 2010
Page reviewed: June 28, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.